Researchers at MIT have just developed a new lipid nanoparticle that super-enhances the effectiveness of the mRNA vaccine in ...

Shah Capital, Novavax's second-largest shareholder, is pressing the biotech's board to pursue strategic changes, including a ...

The 2025-2026 respiratory viral season is approaching.With it comes the familiar challenge of protecting our most vulnerable ...

Q3 2025 Earnings Call Transcript November 6, 2025 Novavax, Inc. misses on earnings expectations. Reported EPS is $-1.24654 ...

Novavax Inc (NVAX) focuses on innovation and partnerships amid financial hurdles, aiming for profitability by 2028.

Novavax raised its annual revenue forecast for the third time this year on Thursday, banking on milestone payments from ...

Novavax, Inc. (Nasdaq: NVAX) today announced its financial results and operational highlights for the third quarter ended ...

GAITHERSBURG, Md. (AP) — GAITHERSBURG, Md. (AP) — Novavax Inc. (NVAX) on Thursday reported a loss of $202.4 million in its third quarter. On a per-share basis, the Gaithersburg, Maryland-based company ...

Pfizer Inc said on Monday its experimental vaccine was more than 90% effective in preventing COVID-19 based on initial data from a large study, a major victory in the fight against the pandemic.

The influenza epidemic period is likely to end this week, but cases are expected to rise again next month and could be more serious than the current wave, the Centers for Disease Control (CDC) said ...

Personalized vaccines that steer the immune system to fight unique cancer cells show promise, but another powerful way to treat cancer might be hiding in plain sight. People being treated for advanced ...

Proposals to remove the CDC's recommendation for the Hepatitis B vaccine at birth are causing concern. The vaccine has reduced newborn infections from as many as 20,000 per year to fewer than 20. An ...